Recently, Lei Ping, a member of the party group and deputy director of the State Drug Administration, led a team to Nanjing, Suzhou, Changzhou and other places in Jiangsu to conduct research, visit innovative medical device companies and medical institutions, and learn more about innovative research and development of high-end medical devices and the progress of the “Spring Rain Campaign” to transform clinical innovation achievements in medical devices. Lei Ping stressed that it is necessary to further improve mechanisms to support the development of innovative medical devices, increase support for high-end medical device research and development, and cultivate new productivity in the pharmaceutical industry. It is necessary to continue to further advance the “Spring Rain Campaign”, accelerate the construction of an innovative ecosystem of “source of clinical creativity - collaborative medical technology research - joint cultivation and empowerment between the central government and the local government”, concentrate resources to support the transformation of clinical innovation results in medical devices, help accelerate the launch of clinically needed medical devices, and better protect the health of the masses.

Recently, Lei Ping, a member of the party group and deputy director of the State Drug Administration, led a team to Nanjing, Suzhou, Changzhou and other places in Jiangsu to conduct research, visit innovative medical device companies and medical institutions, and learn more about innovative research and development of high-end medical devices and the progress of the “Spring Rain Campaign” to transform clinical innovation achievements in medical devices. Lei Ping stressed that it is necessary to further improve mechanisms to support the development of innovative medical devices, increase support for high-end medical device research and development, and cultivate new productivity in the pharmaceutical industry. It is necessary to continue to further advance the “Spring Rain Campaign”, accelerate the construction of an innovative ecosystem of “source of clinical creativity - collaborative medical technology research - joint cultivation and empowerment between the central government and the local government”, concentrate resources to support the transformation of clinical innovation results in medical devices, help accelerate the launch of clinically needed medical devices, and better protect the health of the masses.